Yfat Kadan, MD, has been named assistant professor in the Department of Obstetrics and Gynecology. She will see patients at Lattimore Medical Center as well as Highland Hospital. Most recently, she served as a faculty member in the Department of Gynecologic Oncology at Chaim Sheba Medical Center at ...

Languages

English, Hebrew

Faculty Appointments

Assistant Professor - Department of Obstetrics and Gynecology (SMD)

Credentials

Residency & Fellowship

Fellowship, Gynecologic Oncology, Women and Infants Hospital of Rhode Island. 2012 - 2014

Residency, Obstetrics & Gynecology, HaEmek Medical Center (Israel). 2004 - 2011

Education

MD | Ben Gurion University (Israel). Obstetrics & Gynecology, Reproductive Endocrinology. 2004

Publications

Journal Articles

Outcomes of low-risk endometrial cancer with isolated tumor cells in the sentinel lymph nodes: a prospective, multi-center, single-arm, observational study (ENDO-ITC study).

De Vitis LA, Bogani G, Raspagliesi F, Arencibia Sanchez O, Navarro B, Multinu F, Zanagnolo V, Baiocchi G, De Brot L, Fanfani F, Capasso I, Piedimonte S, DeGuerke L, Buda A, Mauro J, Alessio M, Filipello F, Beiner M, Kadan Y, Papadia A, Vizzielli G, Restaino S, Grassi T, Landoni F, Bianchi T, Grimm C, Polterauer S, Ricotta G, Martinez A, Buderath P, Kimmig R, Chiantera V, Zand B, Zapardiel I, Hernandez A, Gill S, Covens A, Dagher C, Meschini T, Cucinella G, Schivardi G, Occhiali T, Lembo A, Palmieri E, Shahi M, Fought AJ, McGree ME, Suman VJ, Abu-Rustum NR, Ramirez PT, Mariani A, Glaser GE

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2025 March 7 :101764. Epub 03/07/2025.

Socioeconomic marginalization is associated with delayed medical consultation among endometrial cancer patients presenting with postmenopausal bleeding.

Abu Zhaya A, Helpman L, Korach J, Yaniv A, Blecher A, Rozanblat O, Yagel I, Kadan Y

Menopause : the journal of the North American Menopause Society.. 2025 March 132 (3):234-239. Epub 02/21/2025.

Bilateral or unilateral tubo-ovarian abscess: exploring its clinical significance.

Yagur Y, Weitzner O, Shams R, Man-El G, Kadan Y, Daykan Y, Klein Z, Schonman R

BMC women's health.. 2023 December 1923 (1):678. Epub 12/19/2023.

Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis.

Nahshon C, Kadan Y, Lavie O, Ostrovsky L, Segev Y

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2023 October 233 (10):1557-1563. Epub 10/02/2023.

Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O

Cancer letters.. 2023 June 1563 :216196. Epub 04/25/2023.

Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.

Bahar-Shany K, Barnabas GD, Deutsch L, Deutsch N, Glick-Saar E, Dominissini D, Sapoznik S, Helpman L, Perri T, Blecher A, Katz G, Yagel I, Rosenblatt O, Shai D, Brandt B, Meyer R, Mohr-Sasson A, Volodarsky-Perel A, Zilberman I, Armon S, Jakobson-Setton A, Eitan R, Kadan Y, Beiner M, Josephy D, Brodsky M, Friedman E, Anafi L, Molchanov Y, Korach J, Geiger T, Levanon K

International journal of cancer.. 2023 February 15152 (4):781-793. Epub 10/23/2022.

Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy.

Weitzner O, Yagur Y, Kadan Y, Fishman A, Zissin R, Ben-Ezry E, Helpman L, Beiner ME

BMC women's health.. 2022 December 1922 (1):531. Epub 12/19/2022.

Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer.

Yfat K, Mariam K, Mario B, Hal H, Dana J, Lina S, Ilan B, Gregory P, Limor H

Gynecologic oncology.. 2022 November 167 (2):256-260. Epub 09/23/2022.

Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers.

Kadan Y, Baron A, Brezinov Y, Ben Arie A, Fishman A, Beiner M

Gynecologic oncology reports.. 2022 February 39 :100917. Epub 12/26/2021.

High grade, advanced, serous ovarian cancer with low serum CA125 levels.

Asali A, Haj-Yehia N, Zehavi T, Perry T, Beiner M, Fishman A, Kadan Y

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.. 2021 October 41 (7):1107-1111. Epub 01/11/2021.

DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O

Cancer letters.. 2021 March 31501 :224-233. Epub 11/19/2020.

Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study.

Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, Leytes S, Lavie O, Ben-Arie A, Amit A, Namazov A, Volodarsky M, Ben-Shachar I, Atlas I, Bruchim I, Kadan Y, Helpman L

Acta obstetricia et gynecologica Scandinavica.. 2021 March 100 (3):444-452. Epub 10/30/2020.

Time interval from biopsy to surgery and risk for adjuvant therapy in patients with low-risk endometrial cancer.

Kadan Y, Asali A, Fishman A, Helpman L, Perri T, Korach J, Beiner M

Surgical oncology.. 2020 December 35 :1-4. Epub 07/25/2020.

The identification of nuclear ?v?3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions.

Seraya-Bareket C, Weisz A, Shinderman-Maman E, Teper-Roth S, Stamler D, Arbib N, Kadan Y, Fishman A, Kidron D, Edelstein E, Ellis M, Ashur-Fabian O

Oncogenesis.. 2020 July 299 (7):69. Epub 07/29/2020.

Ethnic Disparities for Gynecologic Cancers in Israel.

Kadan Y, Fishman A, Helpman L

Journal of racial and ethnic health disparities.. 2020 June 7 (3):421-427. Epub 11/25/2019.

Chemotherapy Toxicity in Mutation Carriers Undergoing First-Line Platinum-Based Chemotherapy.

Weitzner O, Yagur Y, Kadan Y, Beiner ME, Fishman A, Ben Ezry E, Amitai Komem D, Helpman L

The oncologist.. 2019 December 24 (12):e1471-e1475. Epub 07/25/2019.

Conservative management for postmenopausal women with tubo-ovarian abscess.

Yagur Y, Weitzner O, Man-El G, Schonman R, Klein Z, Fishman A, Beiner M, Kadan Y

Menopause : the journal of the North American Menopause Society.. 2019 July 26 (7):793-796. Epub 1900 01 01.

Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.

Barnabas GD, Bahar-Shany K, Sapoznik S, Helpman L, Kadan Y, Beiner M, Weitzner O, Arbib N, Korach J, Perri T, Katz G, Blecher A, Brandt B, Friedman E, Stockheim D, Jakobson-Setton A, Eitan R, Armon S, Brand H, Zadok O, Aviel-Ronen S, Harel M, Geiger T, Levanon K

Molecular & cellular proteomics : MCP.. 2019 May 18 (5):865-875. Epub 02/13/2019.

Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.

Helpman L, Perri T, Lavee N, Hag-Yahia N, Chariski HA, Kalfon S, Derazne E, Beiner ME, Kadan Y, Fishman A, Korach J, Covens A, Gien L

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2019 January 29 (1):133-139. Epub 1900 01 01.

Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.

Yagur Y, Weitzner O, Gemer O, Lavie O, Beller U, Bruchim I, Vaknin Z, Levy T, Rabinovich A, Shachar IB, Meirovitz A, Arie AB, Derazne E, Raban O, Eitan R, Kadan Y, Fishman A, Helpman L

Gynecologic oncology.. 2018 August 150 (2):288-292. Epub 05/26/2018.

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.

Kadan Y, Raviv O, Segev Y, Lavie O, Bruchim I, Fishman A, Michaelson R, Beller U, Helpman L

International journal of gynaecology and obstetrics : the official organ of the International Federation of Gynaecology and Obstetrics.. 2018 July 142 (1):91-96. Epub 04/02/2018.

Predictors for lymph nodes involvement in low risk endometrial cancer.

Kadan Y, Calvino AS, Katz A, Katz S, Moore RG

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.. 2017 May 37 (4):514-518. Epub 03/24/2017.

Predictive factors for the presence of malignant transformation of pelvic endometriosis.

Kadan Y, Fiascone S, McCourt C, Raker C, Granai CO, Steinhoff M, Moore RG

European journal of obstetrics, gynecology, and reproductive biology.. 2015 February 185 :23-7. Epub 12/02/2014.

Comparison between amniotomy, oxytocin or both for augmentation of labor in prolonged latent phase: a randomized controlled trial.

Nachum Z, Garmi G, Kadan Y, Zafran N, Shalev E, Salim R

Reproductive biology and endocrinology : RB&E.. 2010 November 78 :136. Epub 11/07/2010.

Abdominal scar characteristics as a predictor of intra-abdominal adhesions at repeat cesarean delivery.

Salim R, Kadan Y, Nachum Z, Edelstein S, Shalev E

Fertility and sterility.. 2008 December 90 (6):2324-7. Epub 01/07/2008.

Rudimentary horn pregnancy diagnosed by ultrasound and treated by laparoscopy--a case report and review of the literature.

Kadan Y, Romano S

Journal of minimally invasive gynecology.. 2008 15 (5):527-30. Epub 07/10/2008.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.9

Likelihood of recommending this care provider to others

4.8

Explanations the care provider gave you about your problem or condition

4.9

Care provider's efforts to include you in decisions about your care

4.8

Concern the care provider showed for your questions or worries

4.9

Patient Comments

5.0

Very concerned and reassuring.

Dec 22, 2024

5.0

Everyone at this office was very kind and helpful. I felt listened too and my questions were answered in a way I understood.

Dec 21, 2024

5.0

The physician I saw was the best physician I have seen in this office. Prior to this, I did not like coming to this office, but this physician was great. She was so thoughtful

Nov 18, 2024

5.0

I loved the Dr I saw today, she was easy to understand, passionate and caring. She made sure you understood what she was talking about to you about.

Nov 17, 2024

1.6

I was completely dismissed. [...]

Nov 05, 2024

5.0

Dr. Kadan is amazing so thoughtful and explained everything to me. I trust her implicitly

Oct 13, 2024

5.0

This was the best doctor's experience I've had since my problem began! Dr Zhang and Dr Kadan were so caring, and they truly listened to me and included me in all decisions.

Oct 12, 2024